Haimen Pharma Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- No.163, Zhuhai Rd, Binjiang Street, Haimen District, Nantong, Jiangsu 226100, China (CHN)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3011266110 · DUNS 544338970
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-08-25
- NAIDrug Quality Assurance2020-01-10
Drugs this plant is listed as making
5 distinct drugs across 8 products name this site in their FDA label.
- mesalamineLannett Company Inc.
- PosaconazoleLannett Company Inc.
- propafenoneVitruvias Therapeutics
- QuetiapineAlignScience Pharma Inc.
- Sevelamer CarbonateInsignamedex Llc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.